Advertisement
Screener

C4 Therapeutics, Inc. (CCCC) ROA

C4 Therapeutics, Inc. (CCCC) ROA

  • 2026-06-30: ROA -28.22%.
  • 2026-03-31: ROA -31.56%.
  • 2025-12-31: ROA -29.24%.
  • 2025-09-30: ROA -44.85%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-28.22%
2026-03-31-31.56%
2025-12-31-29.24%
2025-09-30-44.85%
2025-06-30-37.63%
2025-03-31-32.32%
2024-12-31-30.12%
2024-09-30-28.05%
2024-06-30-28.30%
2024-03-31-31.65%
2023-12-31-35.20%
2023-09-30-40.52%
2023-06-30-37.29%
2023-03-31-33.16%
2022-12-31-29.75%
2022-09-30-23.11%
2022-06-30-20.18%
2022-03-31-18.34%
2021-12-31-16.55%
2021-09-30-17.73%
2021-06-30-16.50%
2021-03-31-20.16%
2020-12-31-16.58%
2020-09-30-23.81%

Annual ROA

DateROA
2025-12-31-29.24%
2024-12-31-30.12%
2023-12-31-35.20%
2022-12-31-29.75%
2021-12-31-16.55%
2020-12-31-16.58%
2019-12-31-28.83%

Similar stocks

Stock NameCountryMarket CapPE Ratio
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60